AIP and multiple endocrine neoplasia: Out of the five familial cases, three were members of families with a multiple endocrine neoplasia phenotype (two of them with MEN1 mutations) as previously described (Stratakis et al. 2010) and two had a FIPA phenotype (family history of prolactinomas), but tested negative for AIP mutations.